StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences total assets

Total assets on the balance sheet at the end of each period.

Accustem Sciences's total assets was $1.61M at Jun 30, 2026. For fiscal 2025 it was $1.55M, up 2947.0% from the year before. The highest annual figure on record is $1.55M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.55M+2947.0%
FY2024Dec 31, 2024$50.85K-62.0%
FY2023Dec 31, 2023$133.90K-85.8%
FY2022Dec 31, 2022$939.69K-30.6%
FY2021Dec 31, 2021$1.35M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.61M-0.5%
Q1 FY2026Mar 31, 2026$1.55M-0.1%
Q4 FY2025Dec 31, 2025$1.55M+2947.0%
Q3 FY2025Sep 30, 2025$1.57M+1415.4%
Q2 FY2025Jun 30, 2025$1.61M+1055.3%
Q1 FY2025Mar 31, 2025$1.55M+2943.9%
Q4 FY2024Dec 31, 2024$50.85K-62.0%
Q3 FY2024Sep 30, 2024$103.82K-59.7%
Q2 FY2024Jun 30, 2024$139.66K-69.5%
Q1 FY2024Mar 31, 2024$50.94K-79.4%
Q4 FY2023Dec 31, 2023$133.90K-85.8%
Q3 FY2023Sep 30, 2023$257.58K-84.1%
Q2 FY2023Jun 30, 2023$458.53K-80.7%
Q1 FY2023Mar 31, 2023$247.56K-92.4%
Q4 FY2022Dec 31, 2022$939.69K-30.6%
Q3 FY2022Sep 30, 2022$1.62M–
Q2 FY2022Jun 30, 2022$2.38M–
Q1 FY2022Mar 31, 2022$3.25M–
Q4 FY2021Dec 31, 2021$1.35M–

More Accustem Sciences figures

See a number that looks wrong?